Perhaps frequency would increase by educating patients who are undergoing androgen deprivation
therapy about visiting a chiropractor who would then screen for vertebral loss of bone density through x-rays.
Clinical outcomes and testosterone levels following continuous androgen deprivation
(CAD) in patients with relapsing or locally advanced prostate cancer (PC): A post-hoc analysis of the ICELAND study.
Conclusion: Androgen deprivation
therapy results in significantly increased risk of cardiovascular morbidity in patients with prostate cancer however this relationship between ADT and risk of cardiovascular morbidity may be confounded by unmeasured variables like obesity, atherosclerosis and body mass index (BMI) variations.
Editor's Note: "Based on the results of our study, an increased risk of Alzheimer's disease is a potential adverse effect of androgen deprivation
therapy, but further research is needed before considering changes to clinical practice," Dr.
Key clinical point: Forgoing androgen deprivation
therapy cuts rather than raises overall and cardiac mortality in certain patients with prostate cancer, according to their comorbidities.
This guide explains androgen deprivation
therapy to patients with prostate cancer and their loved ones, and how to deal with its side effects.
They die off when starved of androgens, thus prolonging the effects of androgen deprivation
, which ultimately prolongs the patient's life.
Suppression of androgens of testicular origin is the focus of androgen deprivation
bone loss in patients with prostate cancer.
also was seeking approval of the human IgG2 monoclonal antibody to treat and prevent bone loss in women with breast cancer receiving hormone ablation therapy and to treat and prevent bone loss in men with prostate cancer receiving androgen deprivation
Similarly, men who received androgen deprivation
therapy, which reduces levels of male hormones including testosterone, to treat their prostate cancer had an increased risk of bone disorders.
Prostate cancer that cannot be cured may be held back by androgen deprivation
therapy (ADT), which prevents the male hormone testosterone fuelling tumours.